Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival (Q31931730)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival |
scientific article |
Statements
1 reference
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival (English)
1 reference
Massie BM
1 reference
Armstrong PW
1 reference
Cleland JG
1 reference
Horowitz JD
1 reference
Packer M
1 reference
Poole-Wilson PA
1 reference
Rydén L
1 reference
1 January 2001
1 reference
1 reference
161
1 reference
165-171
1 reference
Identifiers
1 reference
1 reference